Private aTyr raises $59m to target autoimmune diseases

San Diego-based aTyr Pharma raised $49 million in Series D equity financing and secured a $10 million loan to support clinical development of therapeutics for autoimmune diseases.

San Diego-based aTyr Pharma raised $49 million in Series D equity financing and secured a $10 million loan to support clinical development of therapeutics for autoimmune diseases.

An undisclosed global public investment fund made an equity investment in aTyr alongside the company's existing venture capital investors Alta...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Musculoskeletal

More from Therapeutic Category